Cancer is the second leading cause of death worldwide. The World Health Organization (WHO) estimates there will be 50% more new cancer cases in 2040 than there are today. At Novartis, we’re committed to unraveling the inner workings of cancer. We’re developing new therapies for a range of common and rare cancers, investing in diverse technology platforms and experimenting with combination approaches.

Reimagining medicine in cancer

We have the passion and the people to help transform lives as we pursue treatments for patients.

Core disease areas

At Novartis, we push the limits of science to develop innovative therapies. These therapies have the potential to be new foundations for cancer care in areas with great unmet need.

Doctor and patient discussing diagnosis

Breast cancer

Novartis aims to tackle breast cancer with bold science, collaboration, and a passion for transforming patient care. We take a bold approach to our research by including patient populations who are often neglected in clinical trials, identifying new pathways or mutations that may play a role in disease progression, and developing therapies to help extend and improve the lives of patients.
Elder woman holding hand of a patient

Lung cancer

Lung cancer is one of the most common cancers worldwide, accounting for more than 2 million new cases diagnosed each year. Novartis is committed to helping the lung cancer community by advancing the science to drive new treatments for lung cancer.
Doctor greeting a patient

Prostate cancer

We are harnessing the innovation of our world-class scientists, strategic partnerships, and one of the industry’s most competitive pipelines to explore the potential of our targeted therapies to address unmet needs in prostate cancer. Our goal is to reduce the global disease burden, extend the lives of patients with prostate cancer, and elevate current standards of care.

Cancer stories

Healthcare professional holding the hands of an elder patient

When you think of the word ‘cancer,’ what are the first words that spring to mind?

Fighter. Hero. Cancer-stricken. The words and metaphors people use to talk about cancer often feel worlds apart from any other disease. But how far does it go? Do words matter?
Portrait of Leanne Pero

Let’s Talk About The C-Word

Talking about cancer can be challenging. Hear from one patient who was inspired to drive change.
Mother and her daughter

Addressing racial disparities in breast cancer screening

Novartis today announced the launch of More Than JustWords, a multiyear commitment to promote health equity in breast cancer.

Latest cancer news

Jun 02, 2023

  • Media Release

Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups

May 11, 2023

  • Media Release

Novartis to feature new PNH and CML scientific data from broad hematology portfolio at European Hematology Association Annual Meeting

Apr 26, 2023

  • Media Release

Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO
View more

 

Clinical trials and pipeline projects

Find cancer-related clinical trials and learn more about the projects in development around cancer.

Clinical trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition.

Pipeline projects

Benefiting from our continued focus on innovation, Novartis has one of the industry’s most competitive pipelines.

Related links

Learn more about the other Novartis core therapeutic areas

Cardiovascular
Hematology
Immunology
Neuroscience